News
Novo Nordisk Offers Ozempic at $499 Per Month to Eligible US Cash-Paying Customers
(Reuters) -Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S. via its own pharmacy, a tie-up with telehealth service GoodRx and other platforms.
The maker of Ozempic is cutting the price of the drug nearly in half for some patients. Novo Nordisk had already cut the ...
Green Matters on MSN8h
Ozempic Sparks Both Weight Loss Success Stories and Major Lawsuits in 2025
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...
Reports are emerging of women experiencing changes in their genital area, dubbed 'Ozempic vulva,' linked to rapid weight loss ...
Fact checked by Nick Blackmer With anti-obesity medications like Ozempic, Wegovy, and Zepbound exploding in popularity in ...
Ozempic faces over 1,800 lawsuits in US courts, with damages possibly topping $2 billion. Patients allege the drug caused ...
The Little Mix singer said she auditioned for "The X Factor" just months after leaving the hospital, where she was treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback